Skip to content

12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain

CompletedNCT02872129
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

A 12-year follow-up of 166 women with fibromyalgia (FM) or chronic widespread pain (CWP) in western Sweden. The 166 women participated in a Randomised Controlled Trial called GAU in 2004-2005, aiming to investigate the effect of pool exercise and patient education. The primary aim of the present study is to examine the change of symptoms after 11-12 years in 166 women with FM or CWP and also investigate predictors of change of symptoms and work ability. The 166 women will be asked to participate in the present follow-up study. The follow-up examination comprises a standardised interview of symptoms and demographic variables, a battery of self-administered questionnaires and tests of physical function.

Study details

Official title
12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain
Sponsor
Göteborg University
Collaborators
Vastra Gotaland Region
Start date
2016-05
Primary completion
2016-12
Sex
Female
Results posted
No results posted in this snapshot
Countries
Sweden
Total sites listed
3

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria of the present study GAU-U: * All 166 patients who participated in the study GAU in 2004/2005. (The inclusion criteria of GAU was women with FM or CWP, 18-60 years old. Patients with widespread pain; pain in the right and left side of the body, above and below the waist, as well as axial pain, for at least three months were classified as chronic widespread pain (CWP). Patients who fulfilled the criteria for CWP and who also had pain at palpation of at least 11 of 18 pre-defined tender points were classified as fibromyalgia (FM). Exclusion criteria for GAU was serious physical or psychological disease) Exclusion Criteria of the present study GAU-U: * Patients who has developed serious physical or psychological disease since participating in the GAU 2004/2005

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02872129